tenk.fyi

RELMADA THERAPEUTICS, INC.

RLMDNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$57.4M

28.3% YoY

EPS

$-1.45

45.3% YoY

Cash

$3.5M

9.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro